Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 407006
Gene Symbol: MIR221
MIR221 		0.030 Biomarker disease BEFREE Then the effects of miR-221-3p and MAPK10 on cell activities were assessed through gain- and loss-of-function experiments in CC. 31849520 2019
Entrez Id: 5602
Gene Symbol: MAPK10
MAPK10 		0.010 AlteredExpression disease BEFREE Moreover, miR-221-3p was highly expressed and MAPK10 was poorly expressed in CC tissues and cells. 31849520 2019
Entrez Id: 574456
Gene Symbol: MIR497
MIR497 		0.050 Biomarker disease BEFREE miR-497-5p can inhibit cervical cancer cell proliferation. 31849480 2019
Entrez Id: 6367
Gene Symbol: CCL22
CCL22 		0.010 AlteredExpression disease BEFREE CCL22 was primarily expressed in M2-like macrophages in CC and induced by cervical cancer cells. 31842422 2019
Entrez Id: 84793
Gene Symbol: FOXD2-AS1
FOXD2-AS1 		0.010 AlteredExpression disease BEFREE FOXD2-AS1 levels in CC tissues with different tumor sizes and tumor staging were detected. 31841177 2019
Entrez Id: 1044
Gene Symbol: CDX1
CDX1 		0.010 Biomarker disease BEFREE At last, the regulatory effects of FOXD2-AS1/CDX1 on the proliferative ability of CC were examined. 31841177 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274 		0.100 Biomarker disease BEFREE The exception has been the PD-1 inhibitor pembrolizumab in microsatellite instability high (MSI-H) or mismatch repair-deficient (dMMR) advanced endometrial cancers, highlighted by the recent conditional approval of pembrolizumab in recurrent/metastatic PD-L1-positive cervical cancers and the accelerated approval of pembrolizumab and lenvatinib in microsatellite stable (MSS) or mismatch repair-proficient (pMMR) advanced endometrial cancer. 31833942 2020
Entrez Id: 406958
Gene Symbol: MIR182
MIR182 		0.050 Biomarker disease BEFREE In conclusion, our findings demonstrated that PCGEM1-miR-182-FBXW11 axis play an important role in CC progression, and indicated a promising therapeutic target for CC patients. 31832017 2019
Entrez Id: 23291
Gene Symbol: FBXW11
FBXW11 		0.010 Biomarker disease BEFREE In conclusion, our findings demonstrated that PCGEM1-miR-182-FBXW11 axis play an important role in CC progression, and indicated a promising therapeutic target for CC patients. 31832017 2019
Entrez Id: 64002
Gene Symbol: PCGEM1
PCGEM1 		0.010 AlteredExpression disease BEFREE qRT-PCR was performed to investigate PCGEM1 expression levels in CC tissues and cell lines. 31832017 2019
Entrez Id: 4313
Gene Symbol: MMP2
MMP2 		0.100 Biomarker disease BEFREE Tca83 exhibited an E7 to E6 transcript ratio comparable to HeLa (cervix), targeted the ERK1/2 and MMP2 pathways, and was dependent on E6 and E7 to survive and proliferate. 31830929 2019
Entrez Id: 5595
Gene Symbol: MAPK3
MAPK3 		0.050 Biomarker disease BEFREE Tca83 exhibited an E7 to E6 transcript ratio comparable to HeLa (cervix), targeted the ERK1/2 and MMP2 pathways, and was dependent on E6 and E7 to survive and proliferate. 31830929 2019
Entrez Id: 407041
Gene Symbol: MIR34B
MIR34B 		0.030 Biomarker disease BEFREE The objective was to discuss whether exosomal lncRNA HNF1A-AS1 impacted drug resistance in CC via binding to microRNA-34b (miR-34b) and regulating TUFT1 expression. 31827397 2019
Entrez Id: 7286
Gene Symbol: TUFT1
TUFT1 		0.010 AlteredExpression disease BEFREE The objective was to discuss whether exosomal lncRNA HNF1A-AS1 impacted drug resistance in CC via binding to microRNA-34b (miR-34b) and regulating TUFT1 expression. 31827397 2019
Entrez Id: 283460
Gene Symbol: HNF1A-AS1
HNF1A-AS1 		0.010 Biomarker disease BEFREE The objective was to discuss whether exosomal lncRNA HNF1A-AS1 impacted drug resistance in CC via binding to microRNA-34b (miR-34b) and regulating TUFT1 expression. 31827397 2019
Entrez Id: 79068
Gene Symbol: FTO
FTO 		0.010 Biomarker disease BEFREE FTO represents a potential drug candidate for cervical cancer therapy. 31827395 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF 		0.100 GeneticVariation disease BEFREE This meta-analysis proved that TNF-α -238 and -308 G/A polymorphisms could be used to identity individual with elevated susceptibility to cervical cancer in certain populations. 31825934 2019
Entrez Id: 100124700
Gene Symbol: HOTAIR
HOTAIR 		0.400 Biomarker disease BEFREE HOTAIR and TET1 are involved in modulation of the Wnt/β-catenin signaling pathway, but their role in cervical cancer remains to be elucidated. 31820855 2019
Entrez Id: 80312
Gene Symbol: TET1
TET1 		0.020 Biomarker disease BEFREE HOTAIR and TET1 are involved in modulation of the Wnt/β-catenin signaling pathway, but their role in cervical cancer remains to be elucidated. 31820855 2019
Entrez Id: 885
Gene Symbol: CCK
CCK 		0.070 Biomarker disease BEFREE CCK-8 assay, colony formation assay and transwell invasion assay were used to determine the roles of circ-MYBL2 in CC. 31819492 2019
Entrez Id: 494323
Gene Symbol: MIR361
MIR361 		0.040 Biomarker disease BEFREE circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion. 31819492 2019
Entrez Id: 4605
Gene Symbol: MYBL2
MYBL2 		0.030 Biomarker disease BEFREE CCK-8 assay, colony formation assay and transwell invasion assay were used to determine the roles of circ-MYBL2 in CC. 31819492 2019
Entrez Id: 3717
Gene Symbol: JAK2
JAK2 		0.330 Biomarker disease BEFREE JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death. 31817106 2019
Entrez Id: 406991
Gene Symbol: MIR21
MIR21 		0.100 AlteredExpression disease BEFREE We compared miR-21 and Smad7 levels in human samples from chemoradiotherapy-resistance cervical cancer (resistant group) and chemoradiotherapy-sensitive cervical cancer (sensitive group) patients. 31815762 2020
Entrez Id: 4092
Gene Symbol: SMAD7
SMAD7 		0.020 AlteredExpression disease BEFREE We compared miR-21 and Smad7 levels in human samples from chemoradiotherapy-resistance cervical cancer (resistant group) and chemoradiotherapy-sensitive cervical cancer (sensitive group) patients. 31815762 2020